Sara Karlqvist (Sara Rundquist)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Venues

Alimentary pharmacology & therapeutics

The American journal of gastroenterology

Scandinavian journal of gastroenterology

Universitetssjukhuset Örebro

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitetssjukhuset Örebro

Sweden

ST-läkare :: Medicinkliniken

Universitetssjukhuset Örebro

Sweden

AT-läkare

Publications

Sara Karlqvist, Michael C Sachs, Carl Eriksson, Dhanisha Jayesh Trivedi, Scott Montgomery, Jonas F Ludvigsson, Ola Olén, Jonas Halfvarson, null null
Comparative risk of serious infection with vedolizumab vs anti-TNF in inflammatory bowel disease: results from nationwide Swedish registers. The American journal of gastroenterology (2024)
Sara Karlqvist, Michael C Sachs, Carl Eriksson, Dhanisha Jayesh Trivedi, Scott Montgomery, Jonas F Ludvigsson, Ola Olén, Jonas Halfvarson, null null
Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease: Results From Nationwide Swedish Registers. The American journal of gastroenterology (2024)
Sara Karlqvist, Michael C Sachs, Carl Eriksson, Ola Olén, Scott Montgomery, Jonas Halfvarson
Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game-authors' reply. Alimentary pharmacology & therapeutics 53 (5) (2021)
Sara Karlqvist, Michael C Sachs, Carl Eriksson, Ola Olén, Scott Montgomery, Jonas Halfvarson
Letter: vedolizumab or a second anti-TNF-no difference in efficacy for primary biologic failures with IBD. Authors' reply. Alimentary pharmacology & therapeutics 53 (9) (2021)
Sara Karlqvist, Michael C Sachs, Carl Eriksson, Ola Olén, Scott Montgomery, Jonas Halfvarson, null null
Drug survival of anti-TNF agents compared with vedolizumab as a second-line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers. Alimentary pharmacology & therapeutics 53 (4) (2020)
Sara Karlqvist, Carl Eriksson, Linda Nilsson, Leif Angelison, Susanna Jäghult, Jan Björk, Olof Grip, Henrik Hjortswang, Hans Strid, Per Karlén, Scott Montgomery, Jonas Halfvarson
Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG). Scandinavian journal of gastroenterology 53 (10-11) (2018)

Sara Karlqvist.css-eqlu8i{font-size:small;padding-left:4px;} (Sara Rundquist)

Publication Activity (10 Years)

Top Topics

Top Venues

Sara Karlqvist (Sara Rundquist)